Assessing symptom profiles in neuropathic pain clinical trials: Can it improve outcome?

Nadine Attal; Didier Bouhassira; Ralf Baron; Jonathan Dostrovsky; Robert H. Dworkin; Nanna Finnerup; Geoffrey Gourlay; Maija Haanpaa; Srinivasa Raja; Andrew S.C. Rice; David Simpson; Rolf Detlef Treede; Christopher D. Wells

doi:10.1016/j.ejpain.2011.03.005

Assessing symptom profiles in neuropathic pain clinical trials: Can it improve outcome?

Nadine Attal, Didier Bouhassira, Ralf Baron, Jonathan Dostrovsky, Robert H. Dworkin, Nanna Finnerup, Geoffrey Gourlay, Maija Haanpaa, Srinivasa Raja, Andrew S.C. Rice, David Simpson, Rolf Detlef Treede, Christopher D. Wells

Research output: Contribution to journal › Editorial

88 Scopus citations

Original language	English
Pages (from-to)	441-443
Number of pages	3
Journal	European Journal of Pain
Volume	15
Issue number	5
DOIs	https://doi.org/10.1016/j.ejpain.2011.03.005
State	Published - May 2011

Access to Document

10.1016/j.ejpain.2011.03.005

Cite this

@article{a4eadc4a45aa479b8b208f2e7906785d,

title = "Assessing symptom profiles in neuropathic pain clinical trials: Can it improve outcome?",

author = "Nadine Attal and Didier Bouhassira and Ralf Baron and Jonathan Dostrovsky and Dworkin, {Robert H.} and Nanna Finnerup and Geoffrey Gourlay and Maija Haanpaa and Srinivasa Raja and Rice, {Andrew S.C.} and David Simpson and Treede, {Rolf Detlef} and Wells, {Christopher D.}",

note = "Funding Information: David M Simpson MD has served as consultant for Astellas, NeurogeX, Eli Lilly, Astra Zeneca, and Allergan, speaker honoraria from Eli Lilly, Astellas, Pfizer and Allergan, and research grant support from Astra Zeneca, Pfizer, and Allergan. Funding Information: Ralf Baron has received consultancy fees from Pfizer, Genzyme, Grunenthal, Mundipharma, Allergan, Sanofi Pasteur, Medtronic, Eisai, UCB Biosciences, Lilly, Boeringher Ingelheim, Astellas, Novartis and research/grant support from Pfizer, Genzyme and Grunenthal. He is a member of the IMI “Europain” collaboratio and industry members of this are : Astra Zeneca, Pfizer, Esteve, UCB-pharmac, Sanofi Aventis, Grunenthal, Eli Lilly, Neuroscience Technologies and Boehringer Ingelheim. ",

year = "2011",

month = may,

doi = "10.1016/j.ejpain.2011.03.005",

language = "English",

volume = "15",

pages = "441--443",

journal = "European Journal of Pain",

issn = "1090-3801",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Assessing symptom profiles in neuropathic pain clinical trials

T2 - Can it improve outcome?

AU - Attal, Nadine

AU - Bouhassira, Didier

AU - Baron, Ralf

AU - Dostrovsky, Jonathan

AU - Dworkin, Robert H.

AU - Finnerup, Nanna

AU - Gourlay, Geoffrey

AU - Haanpaa, Maija

AU - Raja, Srinivasa

AU - Rice, Andrew S.C.

AU - Simpson, David

AU - Treede, Rolf Detlef

AU - Wells, Christopher D.

N1 - Funding Information: David M Simpson MD has served as consultant for Astellas, NeurogeX, Eli Lilly, Astra Zeneca, and Allergan, speaker honoraria from Eli Lilly, Astellas, Pfizer and Allergan, and research grant support from Astra Zeneca, Pfizer, and Allergan. Funding Information: Ralf Baron has received consultancy fees from Pfizer, Genzyme, Grunenthal, Mundipharma, Allergan, Sanofi Pasteur, Medtronic, Eisai, UCB Biosciences, Lilly, Boeringher Ingelheim, Astellas, Novartis and research/grant support from Pfizer, Genzyme and Grunenthal. He is a member of the IMI “Europain” collaboratio and industry members of this are : Astra Zeneca, Pfizer, Esteve, UCB-pharmac, Sanofi Aventis, Grunenthal, Eli Lilly, Neuroscience Technologies and Boehringer Ingelheim.

PY - 2011/5

Y1 - 2011/5

UR - http://www.scopus.com/inward/record.url?scp=79956110909&partnerID=8YFLogxK

U2 - 10.1016/j.ejpain.2011.03.005

DO - 10.1016/j.ejpain.2011.03.005

M3 - Editorial

C2 - 21458336

AN - SCOPUS:79956110909

SN - 1090-3801

VL - 15

SP - 441

EP - 443

JO - European Journal of Pain

JF - European Journal of Pain

IS - 5

ER -